{"DataElement":{"publicId":"11105679","version":"1","preferredName":"Cytokine Release Syndrome Hypoxia Attribution Type","preferredDefinition":"The Cytokine Release Syndrome (CRS) description for the participant's hypoxia (not attributable to any other cause)","longName":"CRSHYPOXIA_RSORRES","context":"AMC","contextVersion":"1","DataElementConcept":{"publicId":"11105642","version":"1","preferredName":"Cytokine Release Syndrome Hypoxia Attribution","preferredDefinition":"A syndrome that occurs after therapeutic infusion of antibodies into the blood and is characterized by nausea, headache, tachycardia, hypotension, rash, and shortness of breath. It is caused by the release of cytokines from the cells that are targeted by the antibodies. Most patients experience a mild to moderate reaction; however, the reaction may be severe and life-threatening._A decrease in the amount of oxygen in the body. Symptoms range from mild (impaired judgment, memory loss, impaired motor coordination) to severe (seizures and coma).:To assign to a cause or source.","longName":"11105641v1.00:2493589v1.00","context":"AMC","contextVersion":"1","ObjectClass":{"publicId":"11105641","version":"1","preferredName":"Cytokine Release Syndrome Hypoxia","preferredDefinition":"A syndrome that occurs after therapeutic infusion of antibodies into the blood and is characterized by nausea, headache, tachycardia, hypotension, rash, and shortness of breath. It is caused by the release of cytokines from the cells that are targeted by the antibodies. Most patients experience a mild to moderate reaction; however, the reaction may be severe and life-threatening._A decrease in the amount of oxygen in the body. Symptoms range from mild (impaired judgment, memory loss, impaired motor coordination) to severe (seizures and coma).","longName":"C78251:C3890","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytokine Release Syndrome","conceptCode":"C78251","definition":"A syndrome that occurs after therapeutic infusion of antibodies into the blood and is characterized by nausea, headache, tachycardia, hypotension, rash, and shortness of breath. It is caused by the release of cytokines from the cells that are targeted by the antibodies. Most patients experience a mild to moderate reaction; however, the reaction may be severe and life-threatening.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hypoxia","conceptCode":"C3890","definition":"A decrease in the amount of oxygen in the body. Symptoms range from mild (impaired judgment, memory loss, impaired motor coordination) to severe (seizures and coma).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E612039B-3118-41D6-E053-731AD00AA6EC","latestVersionIndicator":"Yes","beginDate":"2022-08-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-12","modifiedBy":"TSESU","dateModified":"2022-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2493589","version":"1","preferredName":"Attribution","preferredDefinition":"assigning to a cause or source.","longName":"C25358","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Attribution","conceptCode":"C25358","definition":"To assign to a cause or source.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"17726EBC-10DE-2E0E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-06-30","modifiedBy":"ONEDATA","dateModified":"2006-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E612039B-3119-41D6-E053-731AD00AA6EC","latestVersionIndicator":"Yes","beginDate":"2022-08-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-12","modifiedBy":"TSESU","dateModified":"2022-08-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"11105637","version":"1","preferredName":"Cytokine Release Syndrome Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"11105637v1.00","context":"AMC","contextVersion":"1","type":"Enumerated","dataType":"ALPHANUMERIC","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"None","valueDescription":null,"ValueMeaning":{"publicId":"2577064","version":"1","preferredName":"None","longName":"2577064","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA15-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-22","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E611FDF2-0C08-4148-E053-731AD00A3E11","beginDate":"2022-08-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-12","modifiedBy":"TSESU","dateModified":"2022-08-12","deletedIndicator":"No"},{"value":"Requiring low-flow nasal cannula or blow-by","valueDescription":null,"ValueMeaning":{"publicId":"11105638","version":"1","preferredName":"Requiring Oxygen by Low-flow Nasal Cannula or Blow-by Delivery","longName":"11105638v1.00","preferredDefinition":"An indication that an individual requires oxygen delivered by either a low-flow nasal cannula or a blow-by delivery method.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Requiring Oxygen by Low-flow Nasal Cannula or Blow-by Delivery","conceptCode":"C188944","definition":"An indication that an individual requires oxygen delivered by either a low-flow nasal cannula or a blow-by delivery method.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E611FDF2-0C05-4148-E053-731AD00A3E11","latestVersionIndicator":"Yes","beginDate":"2022-08-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-12","modifiedBy":"TSESU","dateModified":"2023-08-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E611FDF2-0C09-4148-E053-731AD00A3E11","beginDate":"2022-08-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-12","modifiedBy":"TSESU","dateModified":"2022-08-12","deletedIndicator":"No"},{"value":"Requiring high-flow nasal cannula, facemask, nonrebreather mask, or Venturi mask","valueDescription":null,"ValueMeaning":{"publicId":"11105639","version":"1","preferredName":"High-Flow Nasal Cannula Oxygen Therapy","longName":"11105639v1.00","preferredDefinition":"The delivery of heated, humidified, oxygen enriched gas via nasal cannula at flow rates greater than those typically delivered by standard-flow oxygen devices.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High-Flow Nasal Cannula Oxygen Therapy","conceptCode":"C171510","definition":"The delivery of heated, humidified, oxygen enriched gas via nasal cannula at flow rates greater than those typically delivered by standard-flow oxygen devices.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E611FDF2-0C06-4148-E053-731AD00A3E11","latestVersionIndicator":"Yes","beginDate":"2022-08-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-12","modifiedBy":"TSESU","dateModified":"2023-08-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E611FDF2-0C0A-4148-E053-731AD00A3E11","beginDate":"2022-08-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-12","modifiedBy":"TSESU","dateModified":"2022-08-12","deletedIndicator":"No"},{"value":"Requiring positive pressure (e.g. CPAP, BiPAP, intubation, and mechanical ventilation)","valueDescription":null,"ValueMeaning":{"publicId":"11105640","version":"1","preferredName":"Continuous Positive Airway Pressure Or Mechanical Ventilation","longName":"11105640v1.00","preferredDefinition":"A form of non-invasive mechanical pressure support ventilation that uses a continuous positive airway pressure level to support spontaneous breathing activity._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A method to mechanically assist or replace spontaneous breathing in patients by use of a powered device that forces oxygenated air into the lungs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Continuous Positive Airway Pressure","conceptCode":"C124040","definition":"A form of non-invasive mechanical pressure support ventilation that uses a continuous positive airway pressure level to support spontaneous breathing activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mechanical Ventilation","conceptCode":"C70909","definition":"A method to mechanically assist or replace spontaneous breathing in patients by use of a powered device that forces oxygenated air into the lungs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E611FDF2-0C07-4148-E053-731AD00A3E11","latestVersionIndicator":"Yes","beginDate":"2022-08-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-12","modifiedBy":"TSESU","dateModified":"2023-08-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E611FDF2-0C0B-4148-E053-731AD00A3E11","beginDate":"2022-08-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-12","modifiedBy":"TSESU","dateModified":"2022-08-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2181647","version":"1","preferredName":"Type","preferredDefinition":"a subdivision of a particular kind of thing.","longName":"Type","context":"CIP","contextVersion":"2.31","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4A6A07C-55E4-25A1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-03-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-03-08","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E611E297-16D7-3EBD-E053-731AD00A99E1","latestVersionIndicator":"Yes","beginDate":"2022-08-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-12","modifiedBy":"TSESU","dateModified":"2022-08-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"HYPXIA_ATT_TYP","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Select the CRS description for the participant's hypoxia (not attributable to any other cause)","url":null,"context":"AMC"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E617C397-4B4E-7183-E053-731AD00A063F","latestVersionIndicator":"Yes","beginDate":"2022-08-12","endDate":null,"createdBy":"TSESU","dateCreated":"2022-08-12","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":"8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"}}